Director, Government Market Access
CurrentCreating Government and National/Regional accounts market access strategy to secure optimal access and market penetration within the National and Northeast markets contingent upon approval of novel neuroscience asset at start-up biotech. Focus National/Northeast accounts and states: Change Healthcare (OptumRx), State Medicaid (NY, NJ, PA, MA, CT, RI, NH, ME, VT), Excellus BCBS, IHA, MVP, CDPHP, Emblem Health, Fidelis Care, Healthfirst, MetroPlus, Highmark BCBS PA & NY, UPMC, Independence BC/Keystone First, AmeriHealth Caritas, Geisinger, Health Partners, Horizon BCBS, Point32Health, WellSense, Fallon Health, Health New England, MGB Health Plan, NHPRI, NH Healthy Families, Capital Rx, EmpiRx Health.*Engagement of payer customer key decision makers (Pharmacy Directors, Clinical Pharmacists, Trade Relations, Medical Directors, Case Managers) within targeted/focus accounts. Delivering comprehensive introduction and disease state presentations highlighting unmet need and increasing awareness of Karuna Therapeutics.*Market preparation for launch of novel neuroscience product into Northeast and National markets (contingent upon approval). Geographic responsibility generating significant contribution to total number of market access completed and scheduled PIE (Pre-approval Information Exchange) presentations.*Significantly exceed 2023 market access goals through cross-functional collaboration and leadership.*Selected by company to have quote specific to market access and job function posted on social media platform (LinkedIn), positive post responses from industry colleagues and customers.*Chosen by company to present PIE deck to CEO and COO (company founder) on behalf of market access team at national meeting, resulting in approval/certification for market access team to conduct customer PIE meetings.*Continually educating self to develop thorough understanding of IRA (Inflation Reduction Act) and implications for customers and future Karuna Therapeutics’ business.